Search

everythinglearnresearchcommunity

for

Search:↓

Hair loss in men is common, treatable, but not curable.

Experts recommend thorough medical, sexual, and psychosocial assessments for women's sexual dysfunctions, and suggest individualized treatment plans with regular check-ups. They also mention potential use of estrogen and androgen therapy, but with caution due to safety concerns.

Hair follicle stem cells are key for hair and skin regeneration, can be reprogrammed, and have potential therapeutic uses, but also carry a risk of cancer.

Early diagnosis and individualized treatment improve outcomes for Congenital Adrenal Hyperplasia.

The guideline offers practical advice for diagnosing and treating Post-COVID/Long-COVID.

The WNT signaling pathway is important in many diseases and targeting it could offer new treatments.

Protoporphyrin IX is useful in cancer treatment but can cause health problems if not properly regulated.

Some vitamins and minerals like vitamin D and iron can help with certain types of hair loss, but more research is needed for others.

Early detection and intensive treatment of diseases caused by Staphylococcus aureus toxins are crucial for reducing severe health effects.

Low doses of some substances can be beneficial, while high doses can be harmful or toxic.

Minoxidil is the only FDA-approved topical drug for treating male or female pattern hair loss, and other medications like finasteride and dutasteride can also increase hair growth.

Dihydrotestosterone gel improved well-being and sexual function in older men without negatively affecting prostate health.

Finasteride treats enlarged prostate, shrinks it, improves urination, but may cause sexual dysfunction and isn't for women or children.

Engineered exosomes show promise for improving wound healing but face challenges in clinical use.

5-alpha reductase inhibitors can cause sexual side effects like erectile dysfunction and reduced sexual desire, sometimes lasting after stopping the drug.

Some drugs may reduce prostatitis symptoms short-term with few side effects.

Regenerative pharmacology, which combines drugs with regenerative medicine, shows promise for repairing damaged body parts and needs more interdisciplinary research.

The document concludes that research on sulfatase inhibitors should continue due to their potential in treating various diseases, despite some clinical trial failures.

Azathioprine's effectiveness and safety require careful monitoring and more research, especially regarding its use with corticosteroids and the role of TPMT status in patients.

Engineered extracellular vesicles show promise for targeted therapy but need more research for clinical use.

Certain diets can affect skin conditions, but more research is needed to understand these relationships fully.

Drug repurposing is a cost-effective way to find new uses for existing drugs, speeding up treatment development.

Adult skin quickly reacts to short-term environmental and internal stress, leading to various skin issues and the need for protective measures.

Existing drug dexamethasone may lower death risk in severe COVID-19 cases; more research needed for other drugs.

Some Middle Eastern plants may help treat diabetes and could be alternatives to current drugs, but more research is needed.

The document concludes that managing hirsutism involves identifying the cause, using a scoring system for severity, combining cosmetic and medical treatments, encouraging weight loss, and providing psychological support, while noting the need for more research on drug treatments.

Testing for CAG repeat polymorphism in the androgen receptor gene is not currently recommended for managing hypogonadism.

Natural products can help overcome cancer drug resistance.

Rimegepant causes more nausea and skin issues, while ubrogepant causes more muscle issues; personalized treatment is important.

Both types of oral contraceptives improved symptoms and hormone levels in women with PCOS.